Uveitis in peripheral spondyloarthritis patients: an ancillary analysis of the ASAS-PerSpA study

Maria Llop; Jordi Gratacós; Mireia Moreno; Marta Arévalo; Joan Calvet; Maxime Dougados; Clementina López-Medina

doi:10.1177/1759720X221119246

Uveitis in peripheral spondyloarthritis patients: an ancillary analysis of the ASAS-PerSpA study

Ther Adv Musculoskelet Dis. 2022 Sep 5:14:1759720X221119246. doi: 10.1177/1759720X221119246. eCollection 2022.

Authors

Maria Llop¹, Jordi Gratacós^{2

3}, Mireia Moreno¹, Marta Arévalo¹, Joan Calvet^{1

3}, Maxime Dougados⁴, Clementina López-Medina^{4

5}

Affiliations

¹ Rheumatology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), Sabadell, Spain.
² Rheumatology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), C/ Parc Taulí, 1, 08208 Sabadell, Barcelona, Spain.
³ Medicine Department, Universitat Autònoma de Barcelona, Sabadell, Spain.
⁴ Rheumatology Department, Hôpital Cochin, Paris, France.
⁵ Rheumatology Department, Hospital Universitario Reina Sofía/IMIBIC/Universidad de Córdoba, Córdoba, Spain.

Abstract

Background: Acute anterior uveitis (AAU) is the most frequent extra-musculoskeletal manifestation in spondyloarhtritis (SpA). Previous data on AAU focused on axial disease; therefore, it is not well known whether the clinical characteristics of patients with AAU and recurrent AAU differ between patients with axial and peripheral SpA.

Objective: Primary objective was to compare the clinical characteristics of patients with AAU from patients without AAU in axial and peripheral spondyloarthritis (SpA) patients. Secondary objectives were to describe the clinical features of patients with AAU in the subset of patients with peripheral SpA (pSpA) and the clinical characteristics of patients with recurrent AAU in SpA patients.

Design: This is an ancillary analysis of the ASAS-PerSpA study which included 3152 patients, 2719 patients with axSpA and 433 with pSpA according to rheumatologist judgement.

Methods: Recurrent AAU was defined as the presence of two or more episodes of AAU ever. Univariable and multivariable binary logistic regression analyses were conducted to identify factors associated with the presence of AAU ever and the presence of recurrent AAU.

Results: Overall, 663 patients (21%) presented AAU. Of them, 444 (66.9%) presented recurrent episodes. In patients with SpA, HLA-B27 positivity is the most important factor linked to the presence of AAU, odds ratio (OR) = 2.70 (95% CI = 2.04-3.6). In patients with pSpA, HLA-B27 positivity was also the most relevant factor linked to the presence of AAU, OR = 6.08 (95% CI = 2.72-15.68). Moreover, disease duration, younger age and higher body mass index (BMI) were the only factors slightly linked to the presence of recurrent episodes, OR = 1.03 (95% CI = 1.01-1.04), OR = 1.01 (95% CI = 1.00-1.03) and OR = 1.04 (95% CI = 1.01-1.08), respectively.

Conclusion: HLA-B27 positivity is the most relevant factor linked to AAU risk in SpA patients, and this association is even stronger in those patients with pSpA. Moreover, our study did not find an association between HLA-B27 positivity and recurrent AAU in SpA patients.

Keywords: HLA-B27; peripheral spondyloarthritis; spondyloarthritis; uveitis.